Table 2.
Factors Associated With Provider Endorsement of Treating Vignette Patient With Buprenorphine in Primary Care
| Characteristic | # (%) Endorsing Buprenorphine Treatment in Primary Care* |
Odds of Endorsing Buprenorphine in Primary Care (Confidence Interval) |
Adjusted Odds of Endorsing Buprenorphine in Primary Care (Confidence Interval) |
|---|---|---|---|
| Vignette patient characteristics | |||
| Unemployed with heroin and cocaine use | 28 (9) | 0.3 (0.2–0.5) † | 0.2 (0.1–0.4) † |
| Male | 39 (16) | 1.0 (0.6–1.6) | — |
| African American or Hispanic | 52 (15) | 0.8 (0.5–1.3) | — |
| Provider characteristics | |||
| Mean age (per year) | 46 (SD=8.6) | 1.0 (0.97–1.02) | — |
| Provider race/ethnicity | |||
| White | 45 (14) | Reference | Reference |
| Black | 13 (28) | 2.4 (1.2–5.0)† | 3.0 (1.3–6.8) † |
| Hispanic | 7 (20) | 1.6 (0.7–3.9) | 1.4 (0.5–3.6) |
| Other race | 10 (18) | 1.4 (0.6–2.9) | 2.1 (0.9–5.2) |
| Provider Training | |||
| Infectious disease specialist | 8 (7) | Reference | Reference |
| General internist or family physician | 41 (21) | 3.8 (1.7–8.3)† | 2.8 (1.1–7.1) † |
| Physician assistant or nurse practitioner | 32 (18) | 3.3 (1.5–7.4)† | 2.5 (1.0–6.3) † |
| Certified to prescribe buprenorphine | 18 (22) | 1.6 (0.9–2.9)‡ | 0.7 (0.3–1.6) |
| Has prescribed buprenorphine | 8 (40) | 3.7 (1.5–9.3)† | 4.8 (1.2–18.9) † |
| Knows someone with drug problem | 53 (18) | 1.4 (0.8–2.2) | — |
| Provider attitudes | |||
| Strongly agree or agree that… | |||
| Opiate addiction is a treatable illness | 72 (17) | 1.2 (0.5–2.6) | — |
| Opiate addiction treatment and HIV treatment should be kept separate |
6 (10) | 0.5 (0.2–1.2)‡ | 0.4 (0.1–1.3) |
| A drug dependent person who has relapsed several times probably cannot be treated |
1 (4) | 0.2 (0.03–1.7)‡ | 0.4 (0.05–3.2) |
| Most drug-dependent persons are unpleasant to work with | 11 (8) | 0.4 (0.2–0.7)† | 0.4 (0.2–0.9) |
| Concerned that will attract too many drug users if start prescribing* |
12 (12) | 0.7 (0.3–1.3) | — |
| Provider is responsible to screen for drug problems | 74 (17) | 2.0 (0.8–4.8)‡ | 1.1 (0.4–3.2) |
| Provider is responsible to counsel about drug problems | 66 (17) | 1.1 (0.6–2.0) | — |
| Very or moderately confident in… | |||
| Screening for drug problems | 67 (19) | 2.4 (1.3–4.6)† | 2.1 (0.8–4.9) |
| Counseling about drug problems | 52 (20) | 1.8 (1.1–2.9)† | 1.1 (0.6–2.2) |
*
All percentages refer to row percentages. No adjustments were made in the alpha level to account for multiple comparisons.
†
< 0.05
‡
< 0.20